Benjamin F. Edwards & Company, Inc. Astrazeneca PLC Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 36,554 shares of AZN stock, worth $2.44 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

36,554

Previous 36,485 0.19%

Holding current value

$2.44 Million

Previous $2.47 Million 15.33%

% of portfolio

0.05%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $4,609 - $5,577	69 Added 0.19%	36,554 $2.85 Million
Q1 2024 Apr 29, 2024	BUY	$61.03 - $69.57 $7,079 - $8,070	116 Added 0.32%	36,485 $2.47 Million
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $1.37 Million - $1.53 Million	22,137 Added 155.54%	36,369 $2.45 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $27,107 - $29,970	-418 Reduced 2.85%	14,232 $964,000
Q2 2023 Aug 15, 2023	SELL	$69.91 - $75.81 $58,025 - $62,922	-830 Reduced 5.36%	14,650 $1.05 Million
Q1 2023 Apr 27, 2023	SELL	$63.15 - $71.6 $38,079 - $43,174	-603 Reduced 3.75%	15,480 $1.07 Million
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $26,291 - $34,163	-485 Reduced 2.93%	16,083 $1.09 Million
Q3 2022 Oct 28, 2022	BUY	$53.02 - $135.75 $99,200 - $253,988	1,871 Added 12.73%	16,568 $909,000
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $42,963 - $51,576	725 Added 5.19%	14,697 $971,000
Q1 2022 May 04, 2022	SELL	$55.72 - $67.12 $48,364 - $58,260	-868 Reduced 5.85%	13,972 $927,000
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $136,724 - $161,553	2,531 Added 20.56%	14,840 $864,000
Q3 2021 Nov 02, 2021	BUY	$55.56 - $60.79 $137,622 - $150,576	2,477 Added 25.19%	12,309 $739,000
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $96,936 - $120,480	2,002 Added 25.57%	9,832 $589,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $56,686 - $65,436	1,202 Added 18.14%	7,830 $389,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $92,915 - $111,108	1,915 Added 40.63%	6,628 $331,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $115,374 - $132,831	2,174 Added 85.62%	4,713 $258,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $5,990 - $7,688	-139 Reduced 5.19%	2,539 $134,000
Q1 2020 May 07, 2020	SELL	$37.79 - $51.33 $20,935 - $28,436	-554 Reduced 17.14%	2,678 $120,000
Q4 2019 Feb 06, 2020	BUY	$42.46 - $50.46 $39,445 - $46,877	929 Added 40.34%	3,232 $161,000
Q3 2019 Nov 05, 2019	SELL	$40.12 - $45.47 $344,871 - $390,860	-8,596 Reduced 78.87%	2,303 $103,000
Q2 2019 Aug 08, 2019	SELL	$37.28 - $41.68 $39,591 - $44,264	-1,062 Reduced 8.88%	10,899 $450,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $43,652 - $52,914	1,230 Added 11.46%	11,961 $484,000
Q1 2018 Apr 17, 2018	SELL	$32.97 - $36.63 $6,594 - $7,326	-200 Reduced 1.83%	10,731 $375,000
Q3 2017 Oct 24, 2017	BUY	$28.96 - $34.0 $316,561 - $371,654	10,931	10,931 $370,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Astrazeneca PLC Transaction History